Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SURF | Surface Oncology, Inc. | Chief Executive Officer, Director | Sep 8, 2023 | |||
XLO | Xilio Therapeutics, Inc. | Director | Jun 14, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|